Type
Internal restructuring
Country
France
Region
île de France; Hauts-de-Seine;
Location of affected unit(s)
Rueil-Malmaison
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

122 jobs
Number of planned job losses
Job loss
Announcement Date
17 October 2015
Employment effect (start)
2 November 2015
Foreseen end date

Description

The US pharmaceutical group Bristol-Myers Squibb (BMS) announced that 122 workers will be made redundant in the headquarter of its subsidiary UPSA, at Rueil-Malmaison. The job cuts will mainly affect its administrative, support and commercial workforce. The BMS group previously cut 235 positions in 2013 (see previous factsheet).


Sources

  • 17 October 2015: La dépêche du midi
  • 22 October 2015: Le Petit Bleu

Citation

Eurofound (2015), UPSA, Internal restructuring in France, factsheet number 85149, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/85149.